Mino-Wrap - CitiusPharma2018

Mino-Wrap (CITI-101)

Mino-Wrap Overview

Our Mino-Wrap product (CITI-101) is a malleable, bio-absorbable film impregnated with minocycline and rifampin. It is designed to reduce infections associated with the use of breast tissue expanders (TE) used in breast reconstruction surgeries following mastectomies.

mino wrap sample

Mino-Wrap is placed over or wrapped around the TE in the surgical pocket as a solid film. It swells and liquefies in situ for a specified period of time providing extended protection against infection from the most likely pathogens. In January 2019, Citius signed a definitive worldwide license agreement with The University of Texas MD Anderson Cancer Center to develop and commercialize this novel approach to reducing postoperative infections associated with surgical implants. Mino-Wrap is being reviewed by the FDA’s Center for Drug Evaluation and Research (“CDER”) division.

Program Highlights

  • Partnership with a leading cancer center and support from medical thought leaders.
  • Currently in pre-clinical development.
  • Mino-Wrap is designed to allow the temporary tissue expander to be inflated without any restrictions, and to aid in the prevention of infection and biofilm formation on the implant over longer durations than current practice.
  • The current standard of care (SOC) can be improved upon and infection rates reduced.